You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas: Infectious Diseases
25 September 2023 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) announced on Monday that it has signed a new contract valued at a minimum of USD32m with the US Department of Defense ...
25 September 2023 - MicuRx Pharmaceuticals, Inc., a US-based biopharmaceutical company, announced on Friday that it has received Qualified Infectious Disease Product (QIDP) and Fast Track Designation ...
19 September 2023 - Clinical-stage biopharmaceutical company Scancell Holdings plc (AIM: SCLP) has shared promising results from the initial stage of its Phase 2 SCOPE trial involving SCIB1 in combina...
19 September 2023 - ResVita Bio, a US-based synthetic biology startup, announced on Monday that it has received a USD250,000 Phase 1 Small Business Innovation Research (SBIR) grant from the National I...
13 September 2023 - NanoString Technologies (NASDAQ: NSTG), a provider of life science tools for discovery and translational research, announced on Wednesday that it has introduced the GeoMx IO Proteo...
13 September 2023 - Replicate Bioscience, a clinical-stage company, announced on Tuesday that it has dosed its first subject in a phase one trial of RBI-4000 vaccine intended to prevent rabies.This tr...
Related Headlines
Co-Diagnostics names new chief regulatory affairs officer
Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster Vaccines
Roquefort Therapeutics boosts patent portfolio with PCT Filing
Agenus reports Q2 2023 results and key accomplishments
US FDA Approves US Merck Ebola Zaire Vaccine for Use in Children 12 Months of Age and Older